PROTARA THERAPEUTIC INCTARA
ASignal's systematic analysis rates TARA as Bearish.
Reflects the latest available analysis · analyzed Oct 13, 2026
The case on TARA
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong financial health score (0.9)
- Low debt-to-equity ratio (0.02x)
- High cash position ($142.49M cash vs $2.75M debt)
- High current and quick ratios (10.97x, 10.79x)
- RSI deeply oversold (15.93), potential reversal signal
- Negative operating and free cash flow (-$66.13M, -$40.49M)
- Negative return on equity (-45.80%) and return on assets (-28.82%)
- Negative forward P/E (-1.55x) and EV/EBITDA (-0.31x), indicating losses
- Zero net, operating, and gross margins
- No news coverage or Reddit mentions, suggesting lack of market interest
- Price below SMA20, SMA50, and EMA20, indicating strong downtrend
See the full verdict on TARA
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes TARA
Most investors never get a second opinion, let alone several. ASignal runs TARA past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.